Financial reports
10-Q
2013 Q3
Quarterly report
31 Oct 13
10-Q
2013 Q2
Quarterly report
1 Aug 13
10-Q
2013 Q1
Quarterly report
1 May 13
ARS
2012 FY
Annual report to shareholders
19 Apr 13
10-K
2012 FY
Annual report
27 Feb 13
10-Q
2012 Q3
Quarterly report
25 Oct 12
10-Q
2012 Q2
Quarterly report
9 Aug 12
10-Q
2012 Q1
Quarterly report
1 May 12
ARS
2011 FY
Annual report to shareholders
16 Apr 12
Current reports
8-K
Entry into a Material Definitive Agreement
24 Jan 14
8-K
Other Events
14 Nov 13
8-K
Shire to acquire ViroPharma in strategic move to strengthen rare disease portfolio; will augment already strong growth prospects
12 Nov 13
8-K
Results of Operations and Financial Condition
31 Oct 13
8-K
Other Events
3 Sep 13
8-K
Results of Operations and Financial Condition
1 Aug 13
8-K
Viropharma Provides Update from Ongoing Phase 2 Studies of Maribavir for Treatment of Cytomegalovirus (CMV) Infections
27 Jun 13
8-K
Departure of Directors or Certain Officers
24 May 13
8-K
Results of Operations and Financial Condition
1 May 13
8-K
Vice President, Business Development
22 Apr 13
Registration and prospectus
SC TO-I/A
Issuer tender offer statement (amended)
25 Feb 14
15-12G
Securities registration termination
4 Feb 14
25-NSE
Exchange delisting
24 Jan 14
25-NSE/A
Exchange delisting (amended)
24 Jan 14
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Jan 14
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Jan 14
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Jan 14
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Jan 14
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Jan 14
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Jan 14
Proxies
DEF 14A
Definitive proxy
19 Apr 13
DEFA14A
Additional proxy soliciting materials
9 May 12
DEF 14A
Definitive proxy
13 Apr 12
DEF 14A
Definitive proxy
14 Apr 11
DEF 14A
Definitive proxy
13 Apr 10
DEF 14A
Definitive proxy
10 Apr 09
DEF 14A
Definitive proxy
11 Apr 08
DEF 14A
Definitive proxy
30 Apr 07
PRE 14A
Preliminary proxy
19 Apr 07
DEF 14A
Definitive proxy
10 Apr 06
Other
CT ORDER
Confidential treatment order
12 Apr 13
UPLOAD
Letter from SEC
13 Feb 13
CORRESP
Correspondence with SEC
18 Jan 13
UPLOAD
Letter from SEC
11 Jan 13
CORRESP
Correspondence with SEC
14 Dec 12
UPLOAD
Letter from SEC
6 Dec 12
CT ORDER
Confidential treatment order
16 Nov 12
CT ORDER
Confidential treatment order
21 Sep 12
CT ORDER
Confidential treatment order
6 Aug 12
CT ORDER
Confidential treatment order
1 Jun 12